Correction to: J Gastroenterol DOI 10.1007/s00535-017-1396-0
Unfortunately, in the original publication of this article, the copyright line was incorrectly published in PDF as “© The Author(s) 2017” instead of “©The Author(s) 2017 This article is an open access publication” and also the CC-BY description was not included. The description should be as follows.
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
The original article was corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://dx.doi.org/10.1007/s00535-017-1396-0.
Rights and permissions
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
About this article
Cite this article
Kumada, H., Watanabe, T., Suzuki, F. et al. Correction to: Efficacy and safety of glecaprevir/pibrentasvir in HCV-infected Japanese patients with prior DAA experience, severe renal impairment, or genotype 3 infection. J Gastroenterol 53, 689 (2018). https://doi.org/10.1007/s00535-017-1409-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-017-1409-z